$11.99
0.544.72%
At close: Aug 14, 5:00 PM EST
$12.00
0.010.08%
After Hours: Aug 14, 7:37 PM EST
Helus Pharma Inc Analyst Ratings
HELPNASDAQ
Earnings: Q1 2026 Earnings were released on Fri Aug 14th, before the market open
Consensus Rating1
Buy
Highest Price Target1
$70.00
Lowest Price Target1
$8.00
Consensus Price Target1
$34.00
Helus Pharma Analyst Ratings and Price Targets | NASDAQ:HELP | Benzinga
Helus Pharma Inc has a consensus price target of $34 based on the ratings of 4 analysts. The high is $70 issued by HC Wainwright & Co. on July 9, 2026. The low is $8 issued by TD Cowen on April 13, 2026. The 3 most-recent analyst ratings were released by Wells Fargo, HC Wainwright & Co., and Canaccord Genuity on July 27, 2026, July 9, 2026, and July 1, 2026, respectively. With an average price target of $42.67 between Wells Fargo, HC Wainwright & Co., and Canaccord Genuity, there's an implied 255.56% upside for Helus Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
HC Wainwright & Co.
Canaccord Genuity
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Helus Pharma
FAQ
What is the target price for Helus Pharma (HELP) stock?
The latest price target for Helus Pharma (NASDAQ:HELP) was reported by Wells Fargo on July 27, 2026. The analyst firm set a price target for $16.00 expecting HELP to rise to within 12 months (a possible 33.33% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Helus Pharma (HELP)?
The latest analyst rating for Helus Pharma (NASDAQ:HELP) was provided by Wells Fargo, and Helus Pharma initiated their overweight rating.
When was the last upgrade for Helus Pharma (HELP)?
There is no last upgrade for Helus Pharma
When was the last downgrade for Helus Pharma (HELP)?
There is no last downgrade for Helus Pharma.
When is the next analyst rating going to be posted or updated for Helus Pharma (HELP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helus Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helus Pharma was filed on July 27, 2026 so you should expect the next rating to be made available sometime around July 27, 2027.
Is the Analyst Rating Helus Pharma (HELP) correct?
While ratings are subjective and will change, the latest Helus Pharma (HELP) rating was a initiated with a price target of $0.00 to $16.00. The current price Helus Pharma (HELP) is trading at is $12.00, which is within the analyst’s predicted range.
